Article Details

Capivasertib Improves Survival in AI-Resistant, ER+/HER2- Advanced Breast Cancer

Retrieved on: 2022-06-05 16:06:39

Tags for this article:

Click the tags to see associated articles and topics

Capivasertib Improves Survival in AI-Resistant, ER+/HER2- Advanced Breast Cancer. View article details on HISWAI: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-clinical-oncology-asco/asco-2022/capivasertib-fulvestrant-breast-cancer-survival-treatment-risk/

Excerpt

... PI3K/AKT/PTEN pathway alterations did not appear to impact the effects of treatment. ... Continuing Medical Education (CME/CE) Courses.

Article found on: www.cancertherapyadvisor.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up